<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-104165</identifier>
<setSpec>0213-005X</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Cost and cost-effectiveness analysis of the preferred treatment for initial antiretroviral therapy in HIV infected adults according to 2012 GESIDA/National AIDS Plan guidelines</dc:title>
<dc:creator>Vendrell, Belén</dc:creator>
<dc:creator>Cotarelo, Manuel</dc:creator>
<dc:creator>Betegón, Lourdes</dc:creator>
<dc:language>es</dc:language>
<dc:source>Enferm Infecc Microbiol Clin;30(8): 508-509, oct. 2012.</dc:source>
<dc:identifier>ibc-104165</dc:identifier>
<dc:title xml:lang="es">Análisis de costes y de coste/eficacia de las pautas preferentes de GESIDA/Plan Nacional sobre el Sida en 2012 para el tratamiento antirretroviral inicial en adultos infectados por el VIH</dc:title>
<dc:subject>^d24718^s22057</dc:subject>
<dc:subject>^d16645</dc:subject>
<dc:subject>^d29638</dc:subject>
<dc:subject>^d38332^s22073</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d^s22018</dc:subject>
<dc:type>article</dc:type>
<dc:date>201210</dc:date>
</metadata>
</record>
</ibecs-document>
